Brief: Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update
14/05/2025 21:52
May 14 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY, INC. REPORTS FISCAL SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE CITIUS ONCOLOGY INC: QTRLY NET LOSS PER SHARE $-0.11 Source text: ID:nPn3grS1Sa Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Oncology
See all newsCitius Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Citius Oncology Inc expected to post a loss of 5 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel
U.S. STOCKS ON THE MOVE-Dycom Industries, Robinhood, Brown-Forman
Citius rises as lymphoma drug shows benefit in patients before CAR-T therapy